Stock Research for LXRX

LXRX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

LXRX Stock Chart & Research Data

The LXRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


LXRX Due diligence Resources & Stock Charts

The LXRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LXRX Detailed Price Forecast - CNN Money CNN View LXRX Detailed Summary - Google Finance
Yahoo View LXRX Detailed Summary - Yahoo! Finance Zacks View LXRX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View LXRX Trends & Analysis - Trade-Ideas Barrons View LXRX Major Holders - Barrons
NASDAQ View LXRX Call Transcripts - NASDAQ Seeking View LXRX Breaking News & Analysis - Seeking Alpha
Spotlight View LXRX Annual Report - CompanySpotlight.com OTC Report View LXRX OTC Short Report - OTCShortReport.com
TradeKing View LXRX Fundamentals - TradeKing Charts View LXRX SEC Filings - Bar Chart
WSJ View Historical Prices for LXRX - The WSJ Morningstar View Performance/Total Return for LXRX - Morningstar
MarketWatch View the Analyst Estimates for LXRX - MarketWatch CNBC View the Earnings History for LXRX - CNBC
StockMarketWatch View the LXRX Earnings - StockMarketWatch MacroAxis View LXRX Buy or Sell Recommendations - MacroAxis
Bullish View the LXRX Bullish Patterns - American Bulls Short Pains View LXRX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View LXRX Stock Mentions - StockTwits PennyStocks View LXRX Stock Mentions - PennyStockTweets
Twitter View LXRX Stock Mentions - Twitter Invest Hub View LXRX Investment Forum News - Investor Hub
Yahoo View LXRX Stock Mentions - Yahoo! Message Board Seeking Alpha View LXRX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for LXRX - SECform4.com Insider Cow View Insider Transactions for LXRX - Insider Cow
CNBC View LXRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LXRX - OTC Markets
Yahoo View Insider Transactions for LXRX - Yahoo! Finance NASDAQ View Institutional Holdings for LXRX - NASDAQ


Stock Charts

FinViz View LXRX Stock Insight & Charts - FinViz.com StockCharts View LXRX Investment Charts - StockCharts.com
BarChart View LXRX Stock Overview & Charts - BarChart Trading View View LXRX User Generated Charts - Trading View




Latest Financial News for LXRX


Lexicon Pharmaceuticals to Host 2024 Investor Day
Posted on Thursday April 18, 2024

Includes Business and Scientific Updates from Lexicon Executives and Leading Medical Experts in Hypertrophic Cardiomyopathy, Type 1 Diabetes and Diabetic Peripheral Neuropathic PainTHE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a.m. to 12:00 p.m. ET. Business


All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy
Posted on Tuesday April 16, 2024

Lexicon (LXRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).


Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Posted on Wednesday April 03, 2024

THE WOODLANDS, Texas, April 03, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced Jeff Wade, Lexicon’s president and chief financial officer, Tom Garner, Lexicon’s senior vice president and chief commercial officer, and Craig Granowitz, M.D., Ph.D., Lexicon’s senior vice president and chief medical officer, will participate in a moderated discussion at the 23rd Annual Needham Virtual Healthcare conference Wednesday April 10th, 1:30-2:10pm. A simultaneous webca


Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo
Posted on Monday March 25, 2024

THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport proteins (SGLT2 and SGLT1), will be delivered during the American College of Cardiology 73rd Annual Scientific Session & Expo being held April 6 - 8, 2024 in Atlanta, Georgia, including results from a post-hoc evaluation of the efficacy of sotagliflozin in reducing stroke events in


Stock Market & Investing Books

Enter a stock symbol to view the stock details.